Archives of Gynecology and Obstetrics

, Volume 255, Issue 2, pp 65–68 | Cite as

Preoperative and postoperative CA-125 serum levels in primary Fallopian tube carcinoma

  • A. C. Rosen
  • M. Klein
  • H. R. Rosen
  • A. H. Graf
  • M. Lahousen
  • A. Reiner
  • N. Vavra
  • L. Auerbach
Originals

Abstract

Levels of CA-125 were determined pre- and postoperatively in 13 patients with Fallopian tube cancer. Values before surgery were significantly higher (Median 1220 IU/ml, 90–5000 IU/ml) compared with postoperative levels (Median 194 IU/ml, 67–880 IU/ml) (P=0.0052). Correlation analysis with FIGO stage and grading failed to show any statistical significance, but a trend for a positive correlation with FIGO stage and preoperative values could be observed. The CA-125 antigen is expressed by Fallopian tube carcinoma and should therefore be used in diagnosis and follow-up.

Key words

Fallopian tube carcinoma CA-125 serum levels Prognosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bast RC, Klug TL, St. John E (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887PubMedCrossRefGoogle Scholar
  2. Berek JS, Knapp RC, Malkasian GD (1986) CA-125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet Gynecol 67:685–689PubMedCrossRefGoogle Scholar
  3. Crombach G, Zippel HH, Würz H (1985) Erfahrungen mit CA-125, einem Tumormarker für maligne epitheliale Ovarialtumoren. Geburtshilfe Frauenheilkd 45:205–212PubMedCrossRefGoogle Scholar
  4. Davis AP, Fish A, Woolas R, Oram D (1991) Raised serum CA-125 preceding the diagnosis of carcinoma of the fallopian tube: two case reports. Br J Obstet Gynecol 98:602–603Google Scholar
  5. Dodson MG, Ford JH, Averette HE (1970) Clinical aspects of Fallopian tube carcinoma. Obstet Gynecol 36:935–939PubMedGoogle Scholar
  6. Einhorn N, Bast RC, Knapp RC, Tjernberg B, Zurawski VR (1986) Preoperative evaluation od serum CA-125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol 67:414–416PubMedGoogle Scholar
  7. Engeler V, Reinisch E, Schreiner WE (1981) Das primäre Tubenkarzinom. Eine klinische Studie an 37 Patientinnen. Geburtshilfe Frauenheilkd 41:325–329PubMedGoogle Scholar
  8. Hanton EM, Malkasian GD, Dahlin DC, Pratt J (1966) Primary carcinoma of the Fallopian tube. Am J Obstet Gynecol (1966) 94:832–839PubMedGoogle Scholar
  9. Hu CY, Taymor ML, Hertig AT (1950) Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 59:58–67PubMedGoogle Scholar
  10. Jones OV (1965) Primary carcinoma of the uterine tube. Obstet Gynecol 26:122Google Scholar
  11. Klug TL, Bast R, Niloff J, Knapp R, Maroski V (1984) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA-125) associated with human epithelial ovarian carcinomas. Cancer Res 44:1084–1053Google Scholar
  12. Lootsma-Miklosova E, Aalders JG, Willemse PH, de Bruijn HW (1987) Levels of CA-125 in patients with recurrent carcinoma of the fallopian tube: two case histories. Eur J Obstet Gynecol Reprod Biol 24:231–235PubMedGoogle Scholar
  13. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC (1984) CA-125 antigen levels in obstetrics and gynecologic patients. Obstet Gynecol 64:703–707PubMedGoogle Scholar
  14. Niloff JM, Klug TL, Schaetzl E, Zurawski VR, Knapp RC, Bast RC (1984) Elevation of serum CA-125 in carcinoma of the fallopian tube, endometrium and endocervix. Am J Obstet Gynecol 146:1057–1058Google Scholar
  15. Niloff JM, Bast RC, Schaetzl EM, Knapp RC (1985) Predictive value of CA-125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 151:981–986PubMedGoogle Scholar
  16. Rosen A, Sevelda P, Klein M, Spona J, Beck A (1990) A CA-125 score as a prognostic index in patients with ovarian cancer. Arch Gynecol Obstet 247:125–129PubMedGoogle Scholar
  17. Rosen AC, Klein M, Lahousen M, Graf AH, Rainer A, Vavra N (1993) Primary Fallopian carcinoma in Austria. A retrospective multicenterstudy. Br J Cancer 67:605–609Google Scholar
  18. Sevelda P, Salzer H, Dittrich Ch, Pateisky N, Spona J (1987) The diagnostic validity of the tumor marker CA-125 in ovarian cancer patients. Tumor Diagnostik Ther 8:115–120Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • A. C. Rosen
    • 1
  • M. Klein
    • 2
  • H. R. Rosen
    • 3
  • A. H. Graf
    • 4
  • M. Lahousen
    • 5
  • A. Reiner
    • 6
  • N. Vavra
    • 7
  • L. Auerbach
    • 7
  1. 1.Department of Obstetrics and GynecologySMZ-OstViennaAustria
  2. 2.Department of Obstetrics and GynecologyHanusch Medical CentreViennaAustria
  3. 3.Ludwig Boltzmann Institute of Surgical OncologyViennaAustria
  4. 4.Department of Obstetrics and Gynecology of SalzburgAustria
  5. 5.Department of Obstetrics and GynecologyUniversity of GrazAustria
  6. 6.Department of PathologyUniversity of ViennaAustria
  7. 7.Department of Obstetrics and GynecologyUniversity of ViennaAustria

Personalised recommendations